117 related articles for article (PubMed ID: 6683768)
1. Methamphetamine-induced behavioral effects and releases of brain catecholamines and brain concentrations of methamphetamine in mice.
Yamanaka Y; Yamamoto T; Egashira T
Jpn J Pharmacol; 1983 Feb; 33(1):33-40. PubMed ID: 6683768
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine-induced behavioural effects and brain concentrations of methamphetamine and its metabolite amphetamine in mice.
Brien JF; Kitney JC; Peachey JE; Rogers BJ
Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):313-28. PubMed ID: 569889
[TBL] [Abstract][Full Text] [Related]
3. Methamphetamine-induced behavioral alterations following repeated administration of methamphetamine.
Yamanaka Y; Takano R; Egashira T
Jpn J Pharmacol; 1986 Jun; 41(2):147-54. PubMed ID: 3091891
[TBL] [Abstract][Full Text] [Related]
4. Phenytoin potentiates methamphetamine-induced behavior in mice.
Izumi K; Nomoto M; Koja T; Shimizu T; Kishita C; Fukuda T
Pharmacol Biochem Behav; 1984 May; 20(5):803-6. PubMed ID: 6539921
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis.
Hamamura T; Akiyama K; Akimoto K; Kashihara K; Okumura K; Ujike H; Otsuki S
Brain Res; 1991 Apr; 546(1):40-6. PubMed ID: 1677305
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain.
Scheel-Krüger J
Eur J Pharmacol; 1971; 14(1):47-59. PubMed ID: 4396660
[No Abstract] [Full Text] [Related]
7. Methamphetamine-elicited alterations of dopamine- and serotonin-metabolite levels within mu-opioid receptor knockout mice: a microdialysis study.
Lan KC; Ma T; Lin-Shiau SY; Liu SH; Ho IK
J Biomed Sci; 2008 May; 15(3):391-403. PubMed ID: 17934798
[TBL] [Abstract][Full Text] [Related]
8. Brain catecholamine metabolites and behavior in morphine withdrawal.
Swann AC; Elsworth JD; Charney DS; Jablons DM; Roth RH; Redmond DE; Maas JW
Eur J Pharmacol; 1982 Dec; 86(2):167-75. PubMed ID: 6297931
[TBL] [Abstract][Full Text] [Related]
9. [Effect of beta-phenylethylamine on locomotor activity and brain catecholamine metabolism in mice].
Motohashi N; Nakagawara M; Semba J; Ishii K; Watanabe A; Kariya T
Yakubutsu Seishin Kodo; 1983 Sep; 3(2):67-75. PubMed ID: 6659713
[TBL] [Abstract][Full Text] [Related]
10. Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice.
Kubota Y; Ito C; Sakurai E; Sakurai E; Watanabe T; Ohtsu H
J Neurochem; 2002 Nov; 83(4):837-45. PubMed ID: 12421355
[TBL] [Abstract][Full Text] [Related]
11. Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys.
Seiden LS; Fischman MW; Schuster CR
Drug Alcohol Depend; 1976 Feb; 1(3):215-9. PubMed ID: 828106
[No Abstract] [Full Text] [Related]
12. Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice.
Mickley KR; Dluzen DE
Neuroendocrinology; 2004; 79(6):305-16. PubMed ID: 15256808
[TBL] [Abstract][Full Text] [Related]
13. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment.
Nishikawa T; Mataga N; Takashima M; Toru M
Eur J Pharmacol; 1983 Mar; 88(2-3):195-203. PubMed ID: 6133769
[TBL] [Abstract][Full Text] [Related]
14. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898
[TBL] [Abstract][Full Text] [Related]
15. Measurement of 3-methoxy-4-hydroxyphenylglycol (MHPG) in mouse brain by h.p.l.c. with electrochemical detection, as an index of noradrenaline utilisation and presynaptic alpha 2-adrenoceptor function.
Heal DJ; Prow MR; Buckett WR
Br J Pharmacol; 1989 Mar; 96(3):547-56. PubMed ID: 2541844
[TBL] [Abstract][Full Text] [Related]
16. The role of glutamate in behavioral and neurotoxic effects of methamphetamine.
Ohmori T; Abekawa T; Koyama T
Neurochem Int; 1996 Sep; 29(3):301-7. PubMed ID: 8885289
[TBL] [Abstract][Full Text] [Related]
17. Effect of cortisone, aldosterone and nialamide on "amphetamine stereotypies" and brain methamphetamine levels of adrenalectomized rats.
Kobayashi M; Arai E
Psychopharmacologia; 1976 Apr; 46(3):317-24. PubMed ID: 986058
[TBL] [Abstract][Full Text] [Related]
18. Effects of methamphetamine exposure on anxiety-like behavior in the open field test, corticosterone, and hippocampal tyrosine hydroxylase in adolescent and adult mice.
Struntz KH; Siegel JA
Behav Brain Res; 2018 Aug; 348():211-218. PubMed ID: 29680785
[TBL] [Abstract][Full Text] [Related]
19. Ontogeny of enhanced striatal dopamine release in rats with methamphetamine-induced behavioral sensitization.
Tsuchida K; Ujike H; Kanzaki A; Fujiwara Y; Akiyama K
Pharmacol Biochem Behav; 1994 Jan; 47(1):161-9. PubMed ID: 8115418
[TBL] [Abstract][Full Text] [Related]
20. The effect of yohimbine on the turnover of brain catecholamines and serotonin.
Papeschi R; Theiss P
Eur J Pharmacol; 1975 Aug; 33(1):1-12. PubMed ID: 1175676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
